REPL Stock Analysis: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$9.98
1.11 (12.51%)
▲
5d:
+112.34%
30d:
+229.37%
90d:
+37.66%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 28, 2026
0d
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called REPL this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: REPL is 46.3% above its trading range ($6.82). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: REPL is 46.3% above its trading range ($6.82). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $9.98, which is considered extended relative to its 30-day fair value range of $2.68 to $6.82.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $4.47, while resistance sits at $10.41. The stock is showing strong short-term momentum, up 12.5% recently.
Market Sentiment: REPL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.67. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $4.47, while resistance sits at $10.41. The stock is showing strong short-term momentum, up 12.5% recently.
Market Sentiment: REPL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.67. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.68 -
$6.82
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
Protect Your Profits
REPL is technically overbought (RSI 79). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+46.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.5%)
- BEARISH: Trading 53.2% above Wall St target ($4.67)
- WARNING: Recommendation downgraded due to 46.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$2.68 -
$6.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.47
Resistance Level
$10.42
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.84
Wall Street Target
$4.67
(-53.2%)
Share & Embed Analysis
Last updated: June 03, 2026 7:35 PM ET
Data refreshes hourly during market hours. Next update: 8:35 PM
Data refreshes hourly during market hours. Next update: 8:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Sarchi
SELL
6500 shares
2026-04-02
Kapil Dhingra
SELL
3169 shares
2025-12-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
